Acceleron Pharma Inc. XLRN
178.75 0.00 (+0.00%)
Apr 24, 2025, 3:47 PM EDT
177.20 Day range 179.85
52-week range unavailable
Held by funds
4 US ETFs and mutual funds hold XLRN · largest positions
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Price (T.Rowe) Associates Inc | 8.77% | 5,365,133 | 923.34M | Sep 29, 2021 |
| Vanguard Group, Inc. (The) | 8.05% | 4,925,189 | 847.63M | Sep 29, 2021 |
| Avoro Capital Advisors LLC | 6.54% | 4,000,000 | 688.40M | Sep 29, 2021 |
| Blackrock Inc. | 6.50% | 3,972,924 | 683.74M | Sep 29, 2021 |
| Farallon Capital Management Llc | 3.54% | 2,164,663 | 372.54M | Sep 29, 2021 |
| FMR, LLC | 3.39% | 2,072,735 | 356.72M | Sep 29, 2021 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.52% | 1,543,858 | 193.74M | Jun 29, 2021 |
| Price (T.Rowe) New Horizons Fund | 2.34% | 1,432,837 | 179.81M | Jun 29, 2021 |
| Price (T.Rowe) Health Sciences Fund | 2.33% | 1,427,089 | 179.09M | Jun 29, 2021 |
| Vanguard Small-Cap Index Fund | 2.22% | 1,359,230 | 170.57M | Jun 29, 2021 |
| Vanguard Small-Cap Growth Index Fund | 1.40% | 858,419 | 107.72M | Jun 29, 2021 |
| Fidelity Select Portfolios - Biotechnology | 1.38% | 842,586 | 145.01M | Sep 29, 2021 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DABLE HABIB J. | Chief Executive Officer | Sale | Jul 1, 2021 | 98,450 |
| HAMILL LAURA | Director | Stock Award(Grant) | Jan 28, 2021 | 474 |
| KANGO SUJAY R | Officer | Sale | Mar 1, 2021 | 19,396 |
| KEARNEY TERRENCE C | Director | Stock Award(Grant) | Jan 28, 2021 | 6,749 |
| MCCOURT THOMAS A | Director | Sale | Apr 18, 2021 | 6,044 |
| MCLAUGHLIN KEVIN F | Chief Financial Officer | Stock Award(Grant) | Jan 28, 2021 | 10,681 |